DR. KURT STENZEL, M.D.
Osteopathic Medicine at 70 St, New York, NY

License number
New York 083570
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
505 E 70Th St FLOOR 2ND, New York, NY 10021
Phone
(212) 746-1578
(212) 746-8483 (Fax)
(212) 249-4061
(212) 249-4659 (Fax)

Personal information

See more information about KURT STENZEL at radaris.com
Name
Address
Phone
Kurt Stenzel
525 68Th St, New York, NY 10021
(212) 746-6117

Professional information

See more information about KURT STENZEL at trustoria.com
Kurt Stenzel Photo 1
President, Governing Body, Rogsin Kidney Center At The Rogosin Institute

President, Governing Body, Rogsin Kidney Center At The Rogosin Institute

Position:
President, Governing Body, Rogsin Kidney Center at The Rogosin Institute
Location:
Greater New York City Area
Industry:
Medical Practice
Work:
The Rogosin Institute - President, Governing Body, Rogsin Kidney Center


Kurt Stenzel Photo 2
Dr. Kurt Stenzel - MD (Doctor of Medicine)

Dr. Kurt Stenzel - MD (Doctor of Medicine)

Hospitals:
Rogosin and Kidney Foundation
505 E 70Th St SUITE 203, New York 10021
Rogosin &Kidney Foundation
505 E 70Th St SUITE 203, New York 10021
Rogosin and Kidney Foundation
505 E 70Th St SUITE 203, New York 10021
Rogosin &Kidney Foundation
505 E 70Th St SUITE 203, New York 10021
Education:
Medical Schools
Joan Sanford I Weill Medical College Of Cornell University
Graduated: 1958


Kurt Stenzel Photo 3
Cancer-Cell Proliferation-Suppressing Material Produced By Cancer Cells Restricted By Entrapment

Cancer-Cell Proliferation-Suppressing Material Produced By Cancer Cells Restricted By Entrapment

US Patent:
6818230, Nov 16, 2004
Filed:
Jan 3, 2003
Appl. No.:
10/336313
Inventors:
Shirin Asina - New York NY
Kanti Jain - New York NY
Albert L. Rubin - Englewood NJ
Barry Smith - New York NY
Kurt Stenzel - New York NY
Assignee:
The Rogosin Institute - New York NY
International Classification:
A61K 3512
US Classification:
424520, 424 937, 435177, 435178, 435182, 435382, 435395
Abstract:
Compositions of matter are described which contain restricted cancer cells. When so restricted, the cells produce an unexpectedly high amount of material which suppresses cancer cell proliferation. The phenomenon crosses cancer type and species lines. Processes for making these compositions, and their use, are also described.


Kurt Stenzel Photo 4
Cancer-Cell Proliferation-Suppressing Material Produced By Cancer Cells Restricted By Entrapment

Cancer-Cell Proliferation-Suppressing Material Produced By Cancer Cells Restricted By Entrapment

US Patent:
6224912, May 1, 2001
Filed:
Nov 9, 1998
Appl. No.:
9/188476
Inventors:
Shirin Asina - New York NY
Kanti Jain - New York NY
Albert L. Rubin - Englewood NJ
Barry Smith - New York NY
Kurt Stenzel - New York NY
Assignee:
The Rogo Institute - New York NY
International Classification:
A61K 3512, C12N 1110, C12N 1104, C12N 506, C12N 508
US Classification:
424520
Abstract:
A material for suppressing proliferation of cancer cells is produced by entrapping cancer cells in a selectively-permeable structure such as a bead, and culturing the entrapped cells in a culture medium. Entrapment restricts growth of the cancel cells during culturing and causes the cells to produce in the culture medium a material having a molecular weight of at least about 30 kd that suppresses proliferation of cancer cells. The material is separated from the culture medium by filtering the medium through a filter that separates material having a molecular weight of at least about 30 kd from material having a molecular weight of less than 30 kd. The structure that entraps the cells may contain 10,000 to 500,000 cells.


Kurt Stenzel Photo 5
Agarose Coated Agarose Beads Containing Cancer Cells That Produce Material Which Suppresses Cancer Cell Proliferation

Agarose Coated Agarose Beads Containing Cancer Cells That Produce Material Which Suppresses Cancer Cell Proliferation

US Patent:
5888497, Mar 30, 1999
Filed:
Nov 7, 1996
Appl. No.:
8/745063
Inventors:
Kanti Jain - New York NY
Albert L. Rubin - Englewood NJ
Shirin Asina - New York NY
Barry Smith - New York NY
Kurt Stenzel - New York NY
Assignee:
The Rogosin Institute - New York NY
International Classification:
A01N 6300, C12N 1110, C12N 506, C12N 508
US Classification:
424 937
Abstract:
Implantable beads which contain agarose and optionally collagen, and are coated with agarose have incorporated within cells which produce diffusible biological products. The beads may be used as implants to modulate a recipient's immune response. The beads may also be used in an in vitro context to encourage specific types of cells to grow, to produce desirable products in culture, or to suppress growth of certain cells. The implants may also suppress growth of certain cells following administration to a subject. Cancer cells such as renal cancer cells when restricted by being entrapped in the beads produce more of a material that suppresses cancer cell proliferation.


Kurt Stenzel Photo 6
Entrapped Stem Cells And Uses Thereof

Entrapped Stem Cells And Uses Thereof

US Patent:
7838291, Nov 23, 2010
Filed:
Aug 10, 2007
Appl. No.:
11/891526
Inventors:
Bryan Conn - New York NY, US
Barry Smith - New York NY, US
Albert L. Rubin - Engelwood NJ, US
Kurt Stenzel - New York NY, US
Assignee:
The Rogosin Institute - New York NY
International Classification:
C12N 5/00, C12N 5/02
US Classification:
435374, 435375, 435377, 435382, 435395
Abstract:
The invention relates to the stem cells, embryonic stem cells in particular. It has been found that, when these stem cells are entrapped such that their proliferation is inhibited, they produce material which inhibits the proliferation of other, non-entrapped cells, including stem cells and neoplastic and/or hyperproliferative, but otherwise normal cells. It has also been found that entrapped cancer cells will produce material which inhibits the proliferation of stem cells. Further, it has been found that the entrapment of the stem cells inhibits their differentiation and thus the entrapment process can serve as a long-term storage device for maintaining the undifferentiated state of at least a portion of the entrapped cells.


Kurt Stenzel Photo 7
Beads Containing Restricted Cancer Cells Producing Material Suppressing Cancer Cell Proliferation

Beads Containing Restricted Cancer Cells Producing Material Suppressing Cancer Cell Proliferation

US Patent:
7297331, Nov 20, 2007
Filed:
Aug 16, 2004
Appl. No.:
10/919767
Inventors:
Shirin Asina - New York NY, US
Kanti Jain - New York NY, US
Albert L. Rubin - Englewood NJ, US
Barry Smith - New York NY, US
Kurt Stenzel - New York NY, US
Assignee:
The Rogosin Institute - New York NY
International Classification:
A61K 35/12, C12N 11/02, C12N 11/10, C12N 5/00, C12N 5/08
US Classification:
424 937, 435177, 435178, 435182, 435366, 435382, 435395, 435397
Abstract:
Compositions of matter are described which contain restricted cancer cells. When so restricted, the cells produce an unexpectedly high amount of material which suppresses cancer cell proliferation. The phenomenon crosses cancer type and species lines. Processes for making these compositions, and their use, are also described.


Kurt Stenzel Photo 8
Cancer Cell-Inhibiting Culture Medium Produced By Culturing Restricted Entrapped Cancer Cells

Cancer Cell-Inhibiting Culture Medium Produced By Culturing Restricted Entrapped Cancer Cells

US Patent:
7041504, May 9, 2006
Filed:
Dec 12, 2000
Appl. No.:
09/735073
Inventors:
Shirin Asina - New York NY, US
Kanti Jain - New York NY, US
Albert L. Rubin - Englewood NJ, US
Barry Smith - New York NY, US
Kurt Stenzel - New York NY, US
Assignee:
The Rogosin Institute - New York NY
International Classification:
C12N 5/06, C12N 5/08, C12N 11/10, C12N 11/04, A61K 35/12
US Classification:
435382, 424 937, 424520, 435177, 435178, 435182, 435395
Abstract:
Compositions of matter are described which contain restricted cancer cells. When so restricted, the cells produce an unexpectedly high amount of material which suppresses cancer cell proliferation. The phenomenon crosses cancer type and species lines. Processes for making these compositions, and their use, are also described.


Kurt Stenzel Photo 9
Entrapped Stem Cells And Uses Thereof

Entrapped Stem Cells And Uses Thereof

US Patent:
2011027, Nov 10, 2011
Filed:
Jun 9, 2011
Appl. No.:
13/156659
Inventors:
Bryan CONN - New York NY, US
Barry Smith - New York NY, US
Albert L. Rubin - Engelwood NJ, US
Kurt Stenzel - New York NY, US
Marc Rubin - , US
International Classification:
C12N 5/071, C12N 5/0735
US Classification:
435404
Abstract:
The invention relates to the stem cells, embryonic stem cells in particular. It has been found that, when these stem cells are entrapped such that their proliferation is inhibited, they produce material which inhibits the proliferation of other, non-entrapped cells, including stem cells and neoplastic and/or hyperproliferative, but otherwise normal cells. It has also been found that entrapped cancer cells will produce material which inhibits the proliferation of stem cells. Further, it has been found that the entrapment of the stem cells inhibits their differentiation and thus the entrapment process can serve as a long-term storage device for maintaining the undifferentiated state of at least a portion of the entrapped cells.


Kurt Stenzel Photo 10
Composition Of Restricted Cancer Cells Which Produce Cancer Cell Proliferation Suppressive Materials, And Uses Thereof

Composition Of Restricted Cancer Cells Which Produce Cancer Cell Proliferation Suppressive Materials, And Uses Thereof

US Patent:
2007011, May 17, 2007
Filed:
Jan 8, 2007
Appl. No.:
11/650782
Inventors:
Shirin Asina - New York NY, US
Kanti Jain - New York NY, US
Albert Rubin - Englewood NJ, US
Barry Smith - New York NY, US
Kurt Stenzel - New York NY, US
International Classification:
A61K 39/00
US Classification:
424277100
Abstract:
Compositions of matter are described which contain restricted cancer cells. When so restricted, the cells produce an unexpectedly high amount of material which suppresses cancer cell proliferation. The phenomenon crosses cancer type and species lines. Processes for making these compositions, and their use, are also described.